INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG UNCLASSIFIED/ PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// SUBJ/INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG TESTING PANEL - PROGRAM GUIDANCE:
UNCLASSIFIED// ATTENTION INVITED TO ROUTINE R 302132Z DEC 13 PSN 840295K28 FM CNO WASHINGTON DC TO NAVADMIN INFO ZEN/CNO WASHINGTON DC BT UNCLAS SUBJ: INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG UNCLASSIFIED/ PASS TO OFFICE CODES: FM CNO WASHINGTON DC//N1// TO NAVADMIN INFO CNO WASHINGTON DC//N1// UNCLAS N05355// NAVADMIN 334/13 MSGID/GENADMIN/CNO// WASHINGTON DC/N1/DEC// SUBJ/INCLUSION OF SYNTHETIC CANNABINOIDS TO THE STANDARD DRUG TESTING PANEL - PROGRAM GUIDANCE// REF/A/DOC/MEMO/25OCT13/NOTAL// REF/B/DOC/OPNAVINST/4JUN09// NARR/REF A IS UNDER SECRETARY OF DEFENSE (PERSONNEL AND READINESS) MEMORANDUM UPDATE TO THE DEPARTMENT OF DEFENSE DRUG TESTING PANEL. REF B IS OPNAVINST 5350.4D, NAVY ALCOHOL AND DRUG ABUSE PREVENTION AND CONTROL.// RMKS/1. Per ref (a), this NAVADMIN announces navy drug screening labs (NDSL) will add synthetic cannabinoids (SC), also referred to as "spice", "K-2", or "herbal incense", to the standard testing panel for urinalysis samples submitted for testing. Samples submitted to NDSLS for regular urinalysis testing will be tested for SC. Any Sailor whose urinalysis sample is determined to be positive for SC may be considered in violation of the Uniform Code of Military Justice, Article 112A For Drug Misuse/Abuse and subject to administrative and disciplinary actions. Those Sailors found to be drug dependent will be offered treatment prior to their separation, if eligible. 2. Probable cause and command-directed premise code testing, as defined in ref (b), still require authorization from Navy Alcohol and Drug Abuse Prevention Office (OPNAV N170A) before submitting urinalysis samples to Armed Forces Medical Examiner Services. Guidance for authorization testing is available in the Synthetic Drug Urinalysis Operating Guide at www.nadap.navy.mil. 3. Point of contact is Ms. Lanorfeia Parker, Navy Alcohol and Drug Abuse Prevention Office, at 901-874-4249/DSN 882-4249, 901-481-6295, OR via e-mail at lanorfeia.parker@navy.mil. 4. Released by Vice Admiral W. F. Moran, N1.// BT #1201 NNNN UNCLASSIFIED//